MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Development of a Beta-sensing Pathway in Deep brain stimulation to optimise utility of Local field potential recordings using the Percept system. (Newcastle Beta-sensing Algorithm – NBA)

    M. Gibbs, R. Mills, A. Hussain, A. Jenkins, C. Nicholson, N. Pavese, D. Ledingham (Newcastle upon Tyne, United Kingdom)

    Objective: To establish a pathway for utilisation of beta-sensing using the Percept technology which is applicable to real world clinical practice and optimises the utility…
  • 2024 International Congress

    MDS PD e-Diary – a New Patient-Centered Digital Tool for People with Parkinson’s Disease

    P. Rábano-Suárez, MHG. Monje, JA. Vizcarra, SS. Paul, S. Avión, M. Morse, M. Skorvanek, MHS. Tosin, R. Fuller, TH. Turner, M. Dekker, DA. Hall, K. Bergmann, J. Cedarbaum, W. Maetzler, AJ. Espay, P. Martínez-Martín, GT. Stebbins, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)

    Objective: To describe the initial steps to develop a digital diary (e-Diary) for Parkinson’s disease (PD) – an MDS initiative of a novel patient-centered digital…
  • 2024 International Congress

    Speech Biomarkers for Dysarthria in Parkinson’s Disease — Clinical Validation Across two Languages

    J. Tröger, E. Baykara, F. Dörr, J. Rusz, J R. Orozco-Arroyave (Saarbrücken, Germany)

    Objective: To identify reliable speech biomarkers for assessing dysarthria in individuals with Parkinson's disease (PD) and ensuring their clinical validity across languages. Background: This study…
  • 2024 International Congress

    Determining the optimal filtering method for the removal of gait-related movement artefacts from EEG acquired from People with Parkinson’s Disease

    B. Wijntjes (Dublin, Ireland)

    Objective: Development of an adaptive filtering algorithm to remove movement artefacts from EEG data acquired during a dual sensory-motor gait task when performed by People…
  • 2024 International Congress

    Clinical differentiation between dystonic tremor and Parkinson’s disease based on tremor characteristics

    T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Muto, Y. Ito, M. Hashida, T. Ishizaki, S. Kato, D. Nakatsubo, T. Tsugawa, S. Maesawa, M. Sato, K. Hiraga, T. Uematsu, D. Tamakoshi, D. Fukushima, M. Suzuki, R. Saito, M. Katsuno (Nagoya, Japan)

    Objective: We aimed to identify clinical characteristics that are useful for differentiating dystonic tremor (DT) and Parkinson's disease (PD). Background: DT is often challenging to…
  • 2024 International Congress

    Genome-Wide Association Study revealing novel risk loci associated with Age at Onset of Parkinson’s Disease

    YS. Hwang, SY. Jo, SH. Lee, KY. Park, SJ. Chung (Jeonju, Republic of Korea)

    Objective: This study aimed to determine single-nucleotide polymorphisms (SNPs) associated with AAO in Korean PD patients. Background: Age at onset (AAO) of Parkinson’s disease (PD)…
  • 2024 International Congress

    Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

    Objective: (i) To identify complex variants usually not visible by short-read whole exome sequencing in known genes of Parkinson’s disease (PD) such as structural variants…
  • 2024 International Congress

    Latent Genetic Architecture of Parkinson’s Disease Risk factors and Comorbidities

    J. Kim, I. Foote, S. Bandres-Ciga, 23. Research Team, C. Marshall, A. Grotzinger3, A. Singleton, A. Brentnall, C. Blauwendraat, A. Noyce, G. Genetics Program (London, United Kingdom)

    Objective: To comprehensively investigate the genetic relationship between Parkinson’s disease (PD), its risk factors, and comorbidities by constructing a factor model of the shared genetic…
  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    Real-Time Removal of Stimulus Artifact for Closed-Loop Deep Brain Stimulation by Synchronized Sample-And-Hold Artifact Blanking (SSAB): Verification in Animal Model

    YH. Wu, HC. Lin, CW. Huang, CC. Hsieh, MD. Ker (Hsinchu City, Taiwan)

    Objective: To develop and validate a real-time stimulus artifact removal analog front-end (AFE) by synchronized sample-and-hold artifact blanking (SSAB) technique with the Parkinsonian minipig model…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley